Exploring the Effects of Augmented Reality Educational Videos on Anxiety in Patients Undergoing Cardiac Catheterization
This study investigates the effectiveness of augmented reality educational videos in improving anxiety among patients undergoing cardiac catheterization.
The study participants were patients undergoing cardiac catheterization. The control group received routine care, which included standard paper-based educational materials for cardiac catheterization. The experimental group received routine care in addition to viewing cardiac catheterization educational videos through an augmented reality (AR) application.
The Visual Analog Scale for Anxiety (VAS-A), the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A), and physiological indicators were used to assess participants' subjective and objective levels of anxiety. Assessments and measurements were conducted at three time points: before the intervention, immediately after the intervention, and within 6 hours after completion of cardiac catheterization. Due to the characteristics of the HADS-A subscale, it was administered only at two time points: before the intervention and within 6 hours after completion of cardiac catheterization.
The main research questions addressed in this study are:
- What are the differences in anxiety levels among cardiac catheterization patients based on their basic characteristics?
- How effective is the AR intervention in reducing anxiety among patients undergoing cardiac catheterization?
- What are the effects of AR intervention on patients' anxiety levels (VAS-A, HADS-A) and physiological indicators before the intervention, after the intervention, and after the completion of the cardiac catheterization procedure?
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
South Dist
-
Taichung, South Dist, Taiwán, 402306
- Chung Shan Medical University Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Diagnosis requiring conventional cardiac catheterization, such as ischemic heart disease (ICD-10 code: I20-I25.0).
- Individuals aged 20-75 years with full capacity for civil conduction.
- Individuals eligible for AR (Ambient Neurological) experience and without a history of neurological disorders, such as visual or auditory impairments, or epilepsy.
Exclusion Criteria:
- Emergency cardiac catheterization
- History of anxiety disorder, depression, or arrhythmia (e.g., atrial fibrillation)
- Regular use of heart rate suppressants, anti-anxiety medications, and sedatives
- Patients who have only undergone peripheral arteriovenous angiography
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Grupo experimental
|
The experimental group received routine care (paper-based education) before cardiac catheterization and additionally viewed a cardiac catheterization educational video through an augmented reality (AR) application. The AR intervention consisted of an interactive educational video played on a tablet computer for participants to watch. The video content was developed based on findings from the literature review, hospital educational leaflets, and manuals. A professional company was commissioned to create the graphics and programming and develop the AR application. The video presented information related to cardiac catheterization through real-life images, illustrations, and voice narration, with a total duration of approximately 8 minutes. To ensure the quality and rigor of the intervention tool, three cardiology experts were invited to evaluate the content. The Content Validity Index (CVI) of the intervention was 0.85. Routine care consisted of verbal education using an educational leaflet. The leaflet was based on the standard educational materials routinely used in the cardiology department of the hospital and was developed by the hospital nursing department according to clinical practice and relevant care guidelines. The content of the educational leaflet included the causes and symptoms of myocardial infarction, pre-procedure preparation for cardiac catheterization, post-procedure puncture wound care, and key points for self-care after discharge. During the intervention process, participants received verbal education from the researcher before cardiac catheterization, accompanied by explanations using the educational leaflet. The educational session lasted approximately 10 minutes, and participants were encouraged to ask questions to enhance their understanding of the educational content. |
|
Comparador activo: Grupo de control
|
Routine care consisted of verbal education using an educational leaflet. The leaflet was based on the standard educational materials routinely used in the cardiology department of the hospital and was developed by the hospital nursing department according to clinical practice and relevant care guidelines. The content of the educational leaflet included the causes and symptoms of myocardial infarction, pre-procedure preparation for cardiac catheterization, post-procedure puncture wound care, and key points for self-care after discharge. During the intervention process, participants received verbal education from the researcher before cardiac catheterization, accompanied by explanations using the educational leaflet. The educational session lasted approximately 10 minutes, and participants were encouraged to ask questions to enhance their understanding of the educational content. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in anxiety scores measured by the Visual Analog Scale for Anxiety (VAS-A)
Periodo de tiempo: pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
The Visual Analog Scale for Anxiety (VAS-A) is used to assess the subjective level of anxiety.
It consists of a continuous 100-mm horizontal line ranging from 0 to 100 mm, with 0 mm representing no anxiety and 100 mm representing extreme anxiety.
Higher scores indicate greater levels of anxiety.
A VAS-A score of ≥50 mm is considered to represent clinically significant anxie.
|
pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
|
Change in anxiety scores measured by the Hospital Anxiety and Depression Scale-Anxiety Subscale (HADS-A)
Periodo de tiempo: pre-intervention, and within 6 hours after completion of after procedure
|
The Hospital Anxiety and Depression Scale (HADS) consists of 14 items, including 7 anxiety items and 7 depression items.
In this study, only the Hospital Anxiety and Depression Scale-Anxiety Subscale (HADS-A), which contains 7 items, was used.
The HADS-A is scored using a Likert-type scale, with total scores ranging from 0 to 21.
Higher scores indicate greater levels of anxiety.
Scores of 0-7 indicate normal anxiety levels, scores of 8-10 indicate mild anxiety, and scores of 11 or higher indicate severe anxiety.
|
pre-intervention, and within 6 hours after completion of after procedure
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in heart rate
Periodo de tiempo: pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
Assess the level of physiological anxiety through changes in heart rate.
|
pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
|
Change in systolic blood pressure
Periodo de tiempo: pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
Assess the level of physiological anxiety through change in systolic blood pressure
|
pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
|
Change in diastolic blood pressure
Periodo de tiempo: pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
Assess the level of physiological anxiety through change in diastolic blood pressure
|
pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
|
Change in respiratory rate
Periodo de tiempo: pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
Assess the level of physiological anxiety through change in respiratory rate
|
pre-intervention, immediately after the intervention, and within 6 hours after completion of after procedure
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- CSH-2025-A-033
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .